GlassScriptPhysician profile
Jeffrey Corbett
NPI 1669964201
$4,425.48
in general payments reported to CMS, 2019-2025
5 companies · $3,411 in 2025
The $3,411 reported for 2025 was more than what 89% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $1,015 · 2025: $3,411.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,472 · Food and Beverage: $954.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,471.79 |
| Food and Beverage | $953.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,203.60 | 2024-2025 | Triclip, Mitraclip |
| Edwards Lifesciences Corporation | $1,524.53 | 2025 | Evoque |
| Biosense Webster, INC. | $621.76 | 2025 | Carto 3 |
| Abbvie INC. | $55.63 | 2024-2025 | |
| Glaxosmithkline, LLC. | $19.96 | 2024 | Shingrix, Arexvy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Corbett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.